Catalyst Pharmaceuticals, Inc.
CPRX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $690 | $653 | $581 | $518 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $107 | $66 | $72 | $65 |
| Inventory | $28 | $19 | $20 | $20 |
| Other Curr. Assets | $28 | $21 | $13 | $21 |
| Total Curr. Assets | $852 | $759 | $686 | $624 |
| Property Plant & Equip (Net) | $3 | $3 | $3 | $4 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $129 | $138 | $147 | $157 |
| Long-Term Investments | $19 | $21 | $24 | $22 |
| Tax Assets | $48 | $51 | $48 | $46 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $199 | $213 | $223 | $228 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $1,052 | $972 | $909 | $851 |
| Liabilities | – | – | – | – |
| Payables | $9 | $6 | $11 | $17 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $11 | $1 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $119 | $107 | $89 | $103 |
| Total Curr. Liab. | $129 | $113 | $112 | $121 |
| LT Debt | $2 | $3 | $3 | $3 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $3 | $3 | $3 | $3 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $2 | $3 | $3 | $3 |
| Total Liabilities | $131 | $116 | $115 | $124 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | $447 | $394 | $342 | $285 |
| AOCI | $0 | $0 | -$0 | $0 |
| Other Equity | $473 | $462 | $452 | $442 |
| Total Equity | $920 | $856 | $794 | $728 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $1,052 | $972 | $909 | $851 |
| Net Debt | -$687 | -$650 | -$578 | -$514 |